Dr. Kate Godfrey completed her PhD in pharmacy at the University of Auckland, New Zealand, where she investigated neurological correlates of antidepressant response to brain stimulation treatment. Following this, she moved to the Centre for Psychedelic Research at Imperial College London, where she has been leading the implementation of EEG to study the effects of psychedelics on the brain across multiple studies within the centre. She has particular interest in the use of psychedelics as treatment for mental health conditions and developing electrophysiological measures of neuroplasticity for use in psychedelic research.